|
To pay or not to pay? A decision and costutility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy [Correction] CMAJ 2000;162:973 Owing to a copyediting error, the affiliation information for one of the authors of a recent CMAJ article was published incorrectly.1 Susan Foster is with the London School of Hygiene and Tropical Medicine, which is affiliated with the University of London in Britain. The online version is correct. Reference
© 2000 Canadian Medical Association or its licensors |